Background/Aim: The global shortage of donor organs for transplantation has necessitated the expansion of the organ pool through increased use of organs from less ideal donors. Venous systemic oxygen persufflation (VSOP) and oxygenated machine perfusion (OMP) have previously demonstrated beneficial results compared to cold storage (CS) in the preservation of warm-ischemia-damaged kidney grafts. The aim of this study was to compare the efficacy of VSOP and OMP for the preservation of warm-ischemia-damaged porcine kidneys using the recently introduced Ecosol preservation solution compared to CS using Ecosol or histidine-tryptophan-ketoglutarate solution (HTK). Materials and Methods: Kidneys from German Landrace pigs (n = 5/group) were retrieved and washed out with either Ecosol or HTK after 45 min of clamping of the renal pedicle. As controls, kidneys without warm ischemia, cold stored for 24 h in HTK, were employed. Following 24 h of preservation by VSOP, OMP, CS-Ecosol, or CS-HTK, renal function and damage were assessed during 1 h using the isolated perfused porcine kidney model. Results: During reperfusion, urine production was significantly higher in the VSOP and OMP groups than in the CS-HTK group; however, only VSOP could demonstrate lower urine protein concentrations and fractional excretion of sodium, which did not differ from the non-warm-ischemia-damaged control group. VSOP, CS-Ecosol, and controls showed better maintenance of the acid-base balance than CS-HTK. Reduced lipid peroxidation, as reflected in postreperfusion tissue thiobarbituric acid-reactive substance levels, was observed in the VSOP group compared to the OMP group, and the VSOP and CS-Ecosol groups had concentrations similar to the controls. The ratio of reduced to oxidized glutathione was higher in the VSOP, OMP, and CS-Ecosol groups than in the CS-HTK group and controls, with a higher ratio in the VSOP than in the OMP group. Conclusion: VSOP was associated with mitigation of oxidative stress in comparison to OMP and CS. Preservation of warm-ischemia-damaged porcine kidneys by VSOP was improved compared to OMP and CS, and was comparable to preservation of non-warm-ischemia-damaged cold-stored kidneys.

1.
Rossard L, Favreau F, Giraud S, Thuillier R, Le Pape S, Goujon JM, et al: Role of warm ischemia on innate and adaptive responses in a preclinical renal auto-transplanted porcine model. J Transl Med 2013;11:129.
2.
Abt PL, Marsh CL, Dunn TB, Hewitt WR, Rodrigue JR, Ham JM, et al: Challenges to research and innovation to optimize deceased donor organ quality and quantity. Am J Transplant 2013;13:1400-1404.
3.
Kwiatkowski A, Wszoła M, Perkowska-Ptasińska A, Ostrowski K, Domagała P, Fesołowicz S, et al: Influence of preservation method on histopathological lesions of kidney allografts. Ann Transplant 2009;14:10-13.
4.
Salvadori M, Bertoni E: What's new in clinical solid organ transplantation by 2013. World J Transplant 2014;4:243-266.
5.
Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, et al: Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009;360:7-19.
6.
Morrissey PE, Monaco AP: Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 2014;97:258-264.
7.
Watson CJ, Wells AC, Roberts RJ, Akoh JA, Friend PJ, Akyol M, et al: Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial. Am J Transplant 2010;10:1991-1999.
8.
Hoffmann T, Minor T: New strategies and concepts in organ preservation. Eur Surg Res 2014;54:114-126.
9.
Hoyer DP, Gallinat A, Swoboda S, Wohlschlaeger J, Rauen U, Paul A, et al: Influence of oxygen concentration during hypothermic machine perfusion on porcine kidneys from donation after circulatory death. Transplantation 2014;98:944-950.
10.
Thuillier R, Allain G, Celhay O, Hebrard W, Barrou B, Badet L, et al: Benefits of active oxygenation during hypothermic machine perfusion of kidneys in a preclinical model of deceased after cardiac death donors. J Surg Res 2013;184:1174-1181.
11.
Suszynski TM, Rizzari MD, Scott WE 3rd, Tempelman LA, Taylor MJ, Papas KK: Persufflation (or gaseous oxygen perfusion) as a method of organ preservation. Cryobiology 2012;64:125-143.
12.
Bruinsma BG, Avruch JH, Weeder PD, Sridharan GV, Uygun BE, Karimian NG, et al: Functional human liver preservation and recovery by means of subnormothermic machine perfusion. J Vis Exp 2015;98:52777.
13.
Hosgood SA, van Heurn E, Nicholson ML: Normothermic machine perfusion of the kidney: better conditioning and repair? Transpl Int 2015;28:657-664.
14.
Minor T, Scott WE 3rd, Rizzari MD, Suszynski TM, Lüer B, Efferz P, et al: Energetic recovery in porcine grafts by minimally invasive liver oxygenation. J Surg Res 2012;178:e59-e63.
15.
Talbert JL, Riley LH Jr, Sabiston DC Jr, Blalock A: An evaluation of gaseous oxygen perfusion as a method for maintaining renal viability during periods of complete ischemia. Surg Gynecol Obstet 1961;112:593-599.
16.
Reddy MS, Carter N, Cunningham A, Shaw J, Talbot D: Portal Venous Oxygen Persufflation of the Donation after Cardiac Death pancreas in a rat model is superior to static cold storage and hypothermic machine perfusion. Transpl Int 2014;27:634-639.
17.
Treckmann J, Minor T, Saad S, Ozcelik A, Malagó M, Broelsch CE, et al: Retrograde oxygen persufflation preservation of human livers: a pilot study. Liver Transpl 2008;14:358-364.
18.
Rolles K, Foreman J, Pegg DE: A pilot clinical study of retrograde oxygen persufflation in renal preservation. Transplantation 1989;48:339-342.
19.
Doorschodt BM, Schreinemachers MC, Florquin S, Lai W, Sitzia M, Zernecke A, et al: Evaluation of a novel system for hypothermic oxygenated pulsatile perfusion preservation. Int J Artif Organs 2009;32:728-738.
20.
Maathuis MH, Manekeller S, van der Plaats A, Leuvenink HG, 't Hart NA, Lier AB, et al: Improved kidney graft function after preservation using a novel hypothermic machine perfusion device. Ann Surg 2007;246:982-988; discussion 989-991.
21.
Schlegel A, Kron P, Graf R, Clavien PA, Dutkowski P: Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Ann Surg 2014;260:931-937; discussion 937-938.
22.
Minor T, Putter C, Gallinat A, Ose C, Kaiser G, Scherag A, et al: Oxygen persufflation as adjunct in liver preservation (OPAL): study protocol for a randomized controlled trial. Trials 2011;12:234.
23.
Minor T, Pütter C, Gallinat A, Ose C, Kaiser G, Scherag A, et al: Oxygen persufflation as adjunct in liver preservation (OPAL): study protocol for a randomized controlled trial. Trials 2011;12:234.
24.
Kalenski J, Mancina E, Paschenda P, Beckers C, Bleilevens C, Tóthová L, et al: Improved preservation of warm ischemia-damaged porcine kidneys after cold storage in Ecosol, a novel preservation solution. Ann Transplant 2015;20:233-242.
25.
Minor T, Efferz P, Lüer B: Hypothermic reconditioning by gaseous oxygen persufflation after cold storage of porcine kidneys. Cryobiology 2012;65:41-44.
26.
Mancina E, Kalenski J, Paschenda P, Beckers C, Bleilevens C, Boor P, et al: Determination of the preferred conditions for the isolated perfusion of porcine kidneys. Eur Surg Res 2014;54:44-54.
27.
Arana C, Cutando A, Ferrera MJ, Gómez-Moreno G, Worf CV, Bolaños MJ, et al: Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med 2006;35:554-559.
28.
Behuliak M, Pálffy R, Gardlík R, Hodosy J, Halcák L, Celec P: Variability of thiobarbituric acid reacting substances in saliva. Dis Markers 2009;26:49-53.
29.
Taylor MJ, Baicu SC: Current state of hypothermic machine perfusion preservation of organs: the clinical perspective. Cryobiology 2010;60(suppl):S20-S35.
30.
Lüer B, Koetting M, Efferz P, Minor T: Role of oxygen during hypothermic machine perfusion preservation of the liver. Transpl Int 2010;23:944-950.
31.
Bunegin L, Tolstykh GP, Gelineau JF, Cosimi AB, Anderson LM: Oxygen consumption during oxygenated hypothermic perfusion as a measure of donor organ viability. ASAIO J 2013;59:427-432.
32.
Treckmann J, Nagelschmidt M, Minor T, Saner F, Saad S, Paul A: Function and quality of kidneys after cold storage, machine perfusion, or retrograde oxygen persufflation: results from a porcine autotransplantation model. Cryobiology 2009;59:19-23.
33.
Hosgood SA, Nicholson HF, Nicholson ML: Oxygenated kidney preservation techniques. Transplantation 2012;93:455-459.
34.
Molacek J: Retrograde oxygen persufflation of kidney: experiment on an animal. J Transplant Technol Res 2015;5:147-152.
35.
St Peter SD, Imber CJ, Friend PJ: Liver and kidney preservation by perfusion. Lancet 2002;359:604-613.
36.
Stegemann J, Hirner A, Rauen U, Minor T: Gaseous oxygen persufflation or oxygenated machine perfusion with Custodiol-N for long-term preservation of ischemic rat livers? Cryobiology 2009;58:45-51.
37.
Mownah OA, Khurram MA, Ray C, Kanwar A, Stamp S, Rees D, et al: Development of an ex vivo technique to achieve reanimation of hearts sourced from a porcine donation after circulatory death model. J Surg Res 2014;189:326-334.
38.
van der Plaats A, Maathuis MH, 't Hart NA, Bellekom AA, Hofker HS, van der Houwen EB, et al: The Groningen hypothermic liver perfusion pump: functional evaluation of a new machine perfusion system. Ann Biomed Eng 2006;34:1924-1934.
39.
Dutkowski P, Furrer K, Tian Y, Graf R, Clavien PA: Novel short-term hypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg 2006;244:968-976; discussion 976-977.
40.
Devasagayam TP, Boloor KK, Ramasarma T: Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J Biochem Biophys 2003;40:300-308.
41.
Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP, et al: Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochim Biophys Acta 2011;1812:77-86.
42.
Minor T, Klauke H, Vollmar B, Isselhard W, Menger MD: Biophysical aspects of liver aeration by vascular persufflation with gaseous oxygen. Transplantation 1997;63:1843-1846.
43.
Nagelschmidt M, Minor T, Gallinat A, Moers C, Jochmans I, Pirenne J, et al: Lipid peroxidation products in machine perfusion of older donor kidneys. J Surg Res 2013;180:337-342.
44.
Ye S, Dong J, Han B: Protective effect of reduced glutathione and venous systemic oxygen persufflation on rat steatotic graft following liver transplantation. J Surg Res 2010;158:138-146.
45.
Lauschke H, Kötting M, Akbar S, Minor T: Use of taurine as antioxidant in resuscitating livers from non-heart-beating donors by gaseous oxygen persufflation. J Invest Surg 2003;16:7-11.
46.
Fabre E, Conti M, Paradis V, Droupy S, Bedossa P, Legrand A, et al: Impact of different combined preservation modalities on warm ischemic kidneys: effect on oxidative stress, hydrostatic perfusion characteristics and tissue damage. Urol Res 2002;30:89-96.
47.
Minor T, Manekeller S, Sioutis M, Dombrowski F: Endoplasmic and vascular surface activation during organ preservation: refining upon the benefits of machine perfusion. Am J Transplant 2006;6:1355-1366.
48.
D'Amico G, Bazzi C: Pathophysiology of proteinuria. Kidney Int 2003;63:809-825.
49.
Gallinat A, Lüer B, Swoboda S, Rauen U, Paul A, Minor T: Use of the new preservation solution Custodiol-N supplemented with dextran for hypothermic machine perfusion of the kidney. Cryobiology 2013;66:131-135.
50.
Schreinemachers MC, Doorschodt BM, Florquin S, Tolba RH: Comparison of preservation solutions for washout of kidney grafts: an experimental study. Transplant Proc 2009;41:4072-4079.
51.
Bessems M, Doorschodt BM, Hooijschuur O, van Vliet AK, van Gulik TM: Optimization of a new preservation solution for machine perfusion of the liver: which is the preferred colloid? Transplant Proc 2005;37:329-331.
52.
Schreinemachers MC, Doorschodt BM, Florquin S, van den Bergh Weerman MA, Zernecke A, Idu MM, et al: Pulsatile perfusion preservation of warm ischaemia-damaged experimental kidney grafts. Br J Surg 2010;97:349-358.
53.
Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 1988;45:673-676.
54.
Michalk DV, Hoffmann B, Minor T: Taurine reduces renal ischemia/reperfusion injury in the rat. Adv Exp Med Biol 2003;526:49-56.
55.
Licht C, Kriegesmann E, Minor T, Wingenfeld P, Isselhard W, Michalk DV: Influence of taurine supplementation on ischemic preservation of the isolated rat kidney. Adv Exp Med Biol 1998;442:201-206.
56.
Song SW, Tolba RH, Yonezawa K, Manekeller S, Minor T: Exogenous superoxide dismutase prevents peroxynitrite-induced apoptosis in non-heart-beating donor livers. Eur Surg Res 2008;41:353-361.
57.
Minor T, Chung CW, Yamamoto Y, Obara M, Saad S, Isselhard W: Evaluation of antioxidant treatment with superoxide dismutase in rat liver transplantation after warm ischemia. Eur Surg Res 1992;24:333-338.
58.
Jain S, Lee SH, Korneszczuk K, Culberson CR, Southard JH, Berthiaume F, et al: Improved preservation of warm ischemic livers by hypothermic machine perfusion with supplemented University of Wisconsin solution. J Invest Surg 2008;21:83-91.
59.
O'Callaghan JM, Knight SR, Morgan RD, Morris PJ: Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 2012;12:896-906.
60.
Bellamy CA, Nicely B, Mattice BJ, Teaster R: Comparative analysis of clinical efficacy and cost between University of Wisconsin solution and histidine-tryptophan-ketoglutarate. Prog Transplant 2008;18:166-171; quiz 172.
61.
Hemingway A: Some observations on the perfusion of the isolated kidney by a pump. J Physiol 1931;71:201-213.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.